Regarding ovarian cancer, the risk associated with the presence of a BRCA pathogenetic variant gene in the case of BRCA1 and BRCA2 is 44% (95% CI = 36% to 53%) and 17% (95% CI = 11% to 25%), respectively. This evidence concerns the gene BRCA2 and ovarian cancer.